Nature – by Jeffrey M. Perkel – Data from thousands of single cells can be tricky to analyse, but software advances are making it easier.
Single-cell biology is a hot topic these days. And at the cutting edge of the field is single-cell RNA sequencing (scRNA-seq).
Conventional ‘bulk’ methods of RNA sequencing (RNA-seq) process hundreds of thousands of cells at a time and average out the differences. But no two cells are exactly alike, and scRNA-seq can reveal the subtle changes that make each one unique. It can even reveal entirely new cell types.
For instance, after using scRNA-seq to probe some 2,400 immune-system cells, Aviv Regev of the Broad Institute in Cambridge, Massachusetts, and her colleagues came across some dendritic cells that had potent T-cell-stimulating activity (A.-C. Villani et al. Science 356, eaah4573; 2017). Regev says that a vaccine to stimulate these cells could potentially boost the immune system and protect against cancer.
But such discoveries are hard-won. It’s much more difficult to manipulate individual cells than large populations, and because each cell yields only a tiny amount of RNA, there’s no room for error. Another problem is analysing the enormous amounts of data that result — not least because the tools used can be unintuitive.
(read more…)
Nature – by Jeffrey M. Perkel – Data from thousands of single cells can be tricky to analyse, but software advances are making it easier.
Single-cell biology is a hot topic these days. And at the cutting edge of the field is single-cell RNA sequencing (scRNA-seq).
Conventional ‘bulk’ methods of RNA sequencing (RNA-seq) process hundreds of thousands of cells at a time and average out the differences. But no two cells are exactly alike, and scRNA-seq can reveal the subtle changes that make each one unique. It can even reveal entirely new cell types.
For instance, after using scRNA-seq to probe some 2,400 immune-system cells, Aviv Regev of the Broad Institute in Cambridge, Massachusetts, and her colleagues came across some dendritic cells that had potent T-cell-stimulating activity (A.-C. Villani et al. Science 356, eaah4573; 2017). Regev says that a vaccine to stimulate these cells could potentially boost the immune system and protect against cancer.
But such discoveries are hard-won. It’s much more difficult to manipulate individual cells than large populations, and because each cell yields only a tiny amount of RNA, there’s no room for error. Another problem is analysing the enormous amounts of data that result — not least because the tools used can be unintuitive.
(read more…)
Related Posts
RNA Sequencing identifies new tick-borne virus that causes flu-like illness
Worm’s radical transformation shows metamorphosis can change the functions of cells
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Atlas of the brain’s striatum could guide researchers to new drug treatments
Immune cells offer insights on billion-dollar virus
A functionally integrated cross-tissue alternative splicing program during short-term calorie restriction
Dietary oxidized plant sterol shifts macrophage state to fuel aortic inflammation
Unlocking the past – new method helps gain insights into old tissue
Novel AI model trained on RNA-Seq data accurately detects key gene mutations and predicts biomarkers across 32 cancer types
Transcriptomic aging clock reveals age-related molecular patterns in opioid dependence
RNA sequencing helps predict stem cell transplant benefit in pediatric AML
Protein ‘switch’ determines whether liposarcoma cells will become aggressive
Precursor tRNAs sense temperature changes: heat stress-induced capped pre-tRNAs suppress protein synthesis
Ketamine increases neuroplasticity in female mice but not in males
Somatic mutations linked to vascular damage in progeria
Scientists map dormant cancer cells’ hideouts, opening new targets for treatment
Soluble signals released by neighboring cells direct how the human kidney is built
Genetics influence how cancer arises – and how it evolves
RNA-based testing uncovers extraordinary diversity in mutations driving lung cancer
Study offers new insights into why ex-smokers remain at elevated risk of lung disease
Nature – by Jeffrey M. Perkel – Data from thousands of single cells can be tricky to analyse, but software advances are making it easier.
Single-cell biology is a hot topic these days. And at the cutting edge of the field is single-cell RNA sequencing (scRNA-seq).
Conventional ‘bulk’ methods of RNA sequencing (RNA-seq) process hundreds of thousands of cells at a time and average out the differences. But no two cells are exactly alike, and scRNA-seq can reveal the subtle changes that make each one unique. It can even reveal entirely new cell types.
For instance, after using scRNA-seq to probe some 2,400 immune-system cells, Aviv Regev of the Broad Institute in Cambridge, Massachusetts, and her colleagues came across some dendritic cells that had potent T-cell-stimulating activity (A.-C. Villani et al. Science 356, eaah4573; 2017). Regev says that a vaccine to stimulate these cells could potentially boost the immune system and protect against cancer.
But such discoveries are hard-won. It’s much more difficult to manipulate individual cells than large populations, and because each cell yields only a tiny amount of RNA, there’s no room for error. Another problem is analysing the enormous amounts of data that result — not least because the tools used can be unintuitive.
(read more…)
Related Posts
RNA Sequencing identifies new tick-borne virus that causes flu-like illness
Worm’s radical transformation shows metamorphosis can change the functions of cells
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Atlas of the brain’s striatum could guide researchers to new drug treatments
Immune cells offer insights on billion-dollar virus
A functionally integrated cross-tissue alternative splicing program during short-term calorie restriction
Dietary oxidized plant sterol shifts macrophage state to fuel aortic inflammation
Unlocking the past – new method helps gain insights into old tissue
Novel AI model trained on RNA-Seq data accurately detects key gene mutations and predicts biomarkers across 32 cancer types
Transcriptomic aging clock reveals age-related molecular patterns in opioid dependence
RNA sequencing helps predict stem cell transplant benefit in pediatric AML
Protein ‘switch’ determines whether liposarcoma cells will become aggressive
Precursor tRNAs sense temperature changes: heat stress-induced capped pre-tRNAs suppress protein synthesis
Ketamine increases neuroplasticity in female mice but not in males
Somatic mutations linked to vascular damage in progeria
Scientists map dormant cancer cells’ hideouts, opening new targets for treatment
Soluble signals released by neighboring cells direct how the human kidney is built
Genetics influence how cancer arises – and how it evolves
RNA-based testing uncovers extraordinary diversity in mutations driving lung cancer
Study offers new insights into why ex-smokers remain at elevated risk of lung disease
Stay Connected
Submit a Post to the Blog
Recent Posts
Subscribe to the RNA-Seq Blog
RNA-Seq Products & Services